Researchers have developed a blood test that can reveal the composition of cells in tumors, including the interactions between different cell types. This test may be able to predict how well a patient will respond to immunotherapy. The details of the test and its applications are being studied, with some research focusing on its potential to improve precision oncology and understand tumor biology.